Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1, NEJM 2022, n=2,539) FDA DailyMed (current GLP-1 prescribing information) Mayo Clinic Prescription weight-loss drugs MeAgain App Store listing What MeAgain users say about tracking GLP-1 What Our Users Say I've been using the app for about 7 months now and I love how I'm able to track my meals and my daily medication
doi: 10.3389/fimmu.2025.1542735 Received 10 December 2024 Accepted 09 April 2025 Published 01 May 2025 Volume 16 - 2025 Edited by Ana Sanches Silva, National Institute for Agricultural and Veterinary Research (INIAV), Portugal Reviewed by Brandon Marc Lane, Duke University, United States Ujjawal Sharma, Central University of Punjab, India Munkhtuya Tumurkhuu, Wake Forest Baptist Medical Center, United States Updates Copyright 2025 Jechel, Nedelcu, Dragan, Lupu, Starcea, Mocanu, Rosu, Streanga, Russu, Baciu, Danielescu, Salaru, Morariu, Cirstea, Anton and Lupu
It is important to emphasise that whilst these supplements show promise in certain contexts, they should not be considered substitutes for conventional medical treatment, and patients should discuss their use with healthcare professionals
Cell Death & Disease
Among them, 354 genes including a large number of key defense-responsive genes were upregulated while 24 genes were downregulated (Fig
Sports Medicine, 2018